DCC plc has acquired Midsona Manufacturing AB
DCC plc, the sales, marketing, distribution and business support services group, has announced that DCC Healthcare has acquired Midsona Manufacturing AB, a subsidiary of Midsona AB, for US$9 million.
Together with this acquisition, DCC Health & Beauty Solutions has entered into a supply agreement with the vendor, Midsona AB, a Swedish listed company, whose core activity is the sale and marketing of well-known health and dietary supplements in the Nordic market. Tommy Breen, Chief Executive of DCC plc, said: "The acquisition of Midsona Manufacturing AB is in line with DCC Healthcare's strategy to extend its service offering to brand owners in the health & beauty sector and to expand its European customer base."
Midsona Manufacturing AB provides product development, registration, manufacturing and packing services to a range of leading Swedish and international consumer healthcare and health & beauty brand owners. Its product capability includes standard tablets, effervescent tablets, nutritional liquids and sprays, supplied in a variety of packaging formats. The business operates from a licensed facility in Norrköping, south of Stockholm and has 86 employees. The company will be renamed Vitamex Manufacturing AB and will become part of DCC Health & Beauty Solutions.
Midsona AB develops and markets products that help people feel better. The group is one of the Nordic leaders in nutrition and health, herbal remedies, sports nutrition, colds and hygiene.
Oaklins' teams in Sweden and Ireland advised DCC plc throughout the acquisition process. The Irish team's past working relationship with DCC plc together with the Swedish team's local knowledge of the specific industry combined with execution capabilities were key in securing the mandate. The seamless cooperation between the two Oaklins' teams throughout the process facilitated efficient execution and negotiations between the client and the vendor, proving once again the value and competitive advantage of Oaklins in cross-border acquisitions.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more